Skip to content

Behavioural Brain Research

ISSN 1872-7549, 0166-4328

130 papers in the library · 1,076 citations · publishing 1994-2026

Papers

Sort Most recent Most cited

Methodological aspects of studying the mechanisms of consciousness.

Behavioural Brain Research February 15, 2022 Vassiliy Tsytsarev

There are at least two approaches to the definition of consciousness. In the first case, certain aspects of consciousness, called qualia, are considered inaccessible for research from a third person and can only be described through subjective experience. This approach is inextricably linked with the so-called "hard problem of consciousness", that is, the question of why consciousness has...

DOI: 10.1016/j.bbr.2021.113684 (opens in new tab) Full text (opens in new tab) Brain Claustrum Consciousness meter Thalamocortical loop

Towards an animal model of consciousness based on the platform theory.

Behavioural Brain Research February 15, 2022 Armin Zlomuzica, Ekrem Dere

The evolution of intellectual capacities has brought forth a continuum of consciousness levels subserved by neuronal networks of varying complexity. Brain pathologies, neurodegenerative, and mental diseases affect conscious cognition and behavior. Although impairments in consciousness are among the most devastating consequences of neurological and mental diseases, valid and reliable animal...

DOI: 10.1016/j.bbr.2021.113695 (opens in new tab) Full text (opens in new tab) Animal consciousness Behavioral phenotyping Behavioral test battery Composite score +1

Temporo-spatial Theory of Consciousness (TTC) - Bridging the gap of neuronal activity and phenomenal states.

Behavioural Brain Research February 1, 2022 Georg Northoff, Federico Zilio 138 citations

Consciousness and its neural mechanisms remain a mystery. Current neuroscientific theories focus predominantly on the external input/stimulus and the associated stimulus-related activity during conscious contents. Despite all progress, we encounter two gaps: (i) a gap between spontaneous and stimulus-related activity; (ii) a gap between neuronal and phenomenal features. A novel, different, and...

AI ethics in computational psychiatry: From the neuroscience of consciousness to the ethics of consciousness

Behavioural Brain Research December 1, 2021 Wanja Wiese, Karl Friston

Methods used in artificial intelligence (AI) overlap with methods used in computational psychiatry (CP). Hence, considerations from AI ethics are also relevant to ethical discussions of CP. Ethical issues include, among others, fairness and data ownership and protection. Apart from this, morally relevant issues also include potential transformative effects of applications of AI—for instance,...

Dynamic Reconfiguration of Human Brain Networks Across Altered States of Consciousness.

Behavioural Brain Research November 1, 2021 Haiyang Liu, Ke-Hui Hu, Yingjie Peng et al.

Consciousness is supported by rich neuronal dynamics to orchestrate behaviors and conscious processing can be disrupted by general anesthetics. Previous studies suggested that dynamic reconfiguration of large-scale functional network is critical for learning and higher-order cognitive function. During altered states of consciousness, how brain functional networks are dynamically changed and...

Adolescent exposure to delta-9-tetrahydrocannabinol and ethanol heightens sensitivity to fear stimuli.

Behavioural Brain Research October 11, 2021 Cora E Smiley, Heyam K Saleh, Katherine E Nimchuk et al.

Cannabis use disorder (CUD) has doubled in prevalence over the past decade as a nation-wide trend toward legalization allows for increased drug accessibility. As a result, marijuana has become the most commonly used illicit drug in the United States particularly among the adolescent population. This is especially concerning since there is greater risk for the harmful side effects of drug use...

The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice.

Behavioural Brain Research October 1, 2021 Anna Rafało-Ulińska, Agnieszka Pałucha-Poniewiera 46 citations

(S)-ketamine has been approved as a rapid-acting antidepressant drug (RAAD). Although ketamine has an advantage over classic antidepressants (ADs) due to its rapid action, it remains a controversial drug due to its undesirable effects. Behavioral studies indicate that another enantiomer of ketamine, namely, (R)-ketamine, has been proposed as a safer but still effective RAAD. However, these...

Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice

Behavioural Brain Research August 23, 2021 Carolina Aparecida Faria Almeida, Antônio Alves Pereira-Júnior, Jéssica Gonçalves Rangel et al. 33 citations

Alcohol use disorder needs more effective treatments because relapse rates remain high. Psychedelics, such as ayahuasca, have been used to treat substance use disorders. Our study aimed to evaluate the effects of ayahuasca on ethanol-induced behavioral sensitization (EIBS). Swiss mice received 2.2 g/kg ethanol or saline IP injections every other day across nine days (D1, D3, D5, D7, and D9),...

Pairing of neonatal phencyclidine exposure and acute adolescent stress in male rats as a novel developmental model of schizophrenia.

Behavioural Brain Research April 16, 2021 A. Moghadam, Linnea R. Vose, Omid Miry et al.

Improved understanding of the neurophysiological and neurochemical mechanisms underlying schizophrenia is essential for the identification of biological markers and developing new therapeutic targets. The development of behaviorally faithful, predictive animal models is crucial to this endeavor. We have developed a novel two-hit paradigm designed to recapitulate in rodents the developmental...

The causal involvement of the right supramarginal gyrus in the subjective experience of time: A hf-tRNS study.

Behavioural Brain Research February 13, 2021 Giulia Prete, Chiara Lucafò, Gianluca Malatesta et al.

Neural populations in the supramarginal gyrus (SMG) of the right hemisphere have been shown to be involved in processing the subjective experience of time, particularly because of their selectivity to specific temporal durations. To directly investigate this relationship, we applied high-frequency transcranial Random Noise Stimulation (hf-tRNS) on the right SMG during a duration judgment task:...

Out of our heads: Addiction and psychiatric externalism.

Behavioural Brain Research February 1, 2021 Shane N Glackin, Tom Roberts, Joel Krueger 28 citations

In addiction, apparently causally significant phenomena occur at a huge number of levels; addiction is affected by biomedical, neurological, pharmacological, clinical, social, and politico-legal factors, among many others. In such a complex, multifaceted field of inquiry, it seems very unlikely that all the many layers of explanation will prove amenable to any simple or straightforward,...

Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice

Behavioural Brain Research December 28, 2020 Anna U. Odland, Jesper L. Kristensen, Jesper T. Andreasen 60 citations

Psychedelic drugs acting as 5-hydroxyptryptamine 2A receptor (5-HT2AR) agonists have shown promise as viable treatments of psychiatric disorders, including obsessive-compulsive disorder. The marble burying test is a test of compulsive-like behavior in mice, and psychedelics acting as 5-HT2AR agonists can reduce digging in this test. We assessed the 5-HT2R contribution to the mechanisms of two...

DOI: 10.1016/j.bbr.2020.113093 (opens in new tab) Psilocybin Citalopram Hallucinogen Pharmacology +3

Anti-inflammatory activity of ayahuasca: therapeutical implications in neurological and psychiatric diseases

Behavioural Brain Research November 6, 2020 Marina Goulart Da Silva, Guilherme Cabreira Daros, Rafael Mariano de Bitencourt 21 citations

Ayahuasca is a decoction with psychoactive properties, used for millennia for therapeutic and religious purposes by indigenous groups and the population of amazonian countries. As described in this narrative review, it is essentially constituted by β-carbolines and tryptamines, and it has therapeutic effects on behavioral disorders due to the inhibition of the monoamine oxidase enzyme and the...

DOI: 10.1016/j.bbr.2020.113003 (opens in new tab) Ayahuasca Hallucinogen Neuroinflammation Monoamine oxidase +2

Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.

Behavioural Brain Research October 1, 2020 Dionisio A Amodeo, Omron Hassan, Landon M. Klein et al. 25 citations

Serotonin 2A (5-HT2A) receptors are the primary site of action of hallucinogenic drugs and the target of atypical antipsychotics. 5-HT2A receptors are also implicated in executive function, including behavioral flexibility. Previous studies showed that 5-HT2A receptor blockade improved behavioral flexibility in rodent models related to autism spectrum disorder and schizophrenia. The current...

DOI: 10.1016/j.bbr.2020.112861 (opens in new tab) Full text (opens in new tab) Serotonin 5-ht2a Behavioral flexibility Probabilistic reversal learning

Cortical reorganization processes in meditation naïve participants induced by 7 weeks focused attention meditation training.

Behavioural Brain Research October 1, 2020 Lukas Lenhart, Ruth Steiger, Michaela Waibel et al.

Based on the evidence that meditation is associated with numerous beneficial effects on well-being and reduced stress-related symptoms, mindfulness-based techniques were increasingly implemented into psychotherapeutic programs. However, different meditation styles and the cross-sectional nature of most previous analyses resulted in a great variety of morphometric findings. The present study...

DOI: 10.1016/j.bbr.2020.112828 (opens in new tab) Full text (opens in new tab) Neuroplasticity Diffusion-weighted imaging Focused attention meditation Gray matter volume

Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review.

Behavioural Brain Research August 17, 2020 Meryem Grabski, Anna Borissova, Beth Marsh et al.

Esketamine was recently licensed by the US Food and Drug Administration (FDA) and European Drug Agency (EDA) for use in treatment resistant depression (TRD), and further research indicates ketamine as a possible treatment in other mental health conditions. While the underlying mechanisms remain unclear, it has been hypothesised that ketamine's acute psychoactive effects may be associated with...

Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice.

Behavioural Brain Research July 9, 2020 Tomohisa Mori, Naoki Uzawa, Daiki Masukawa et al.

Orexinergic neurons, which are closely associated with narcolepsy, regulate arousal and reward circuits through the activation of monoaminergic neurons. Psychostimulants as well as 5-HT-related compounds have potential in the treatment of human narcolepsy. Previous studies have demonstrated that orexin receptor antagonists as well as orexin deficiencies affect the pharmacological effects of...

Ketamine's Dose Related Multiple Mechanisms of Actions: Dissociative Anesthetic to Rapid Antidepressant.

Behavioural Brain Research May 8, 2020 E. Lavender, Mika Hirasawa-Fujita, E. Domino

Ketamine induces safe and effective anesthesia and displays unusual cataleptic properties that gave rise to the term dissociative anesthesia. Since 1970, clinicians only utilized the drug as an anesthetic or analgesic for decades, but ketamine was found to have rapid acting antidepressant effects in 1990s. Accumulated evidence exhibits NMDAR antagonism may not be the only mechanism of ketamine....

Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Behavioural Brain Research February 13, 2020 S. Kokane, Ross J. Armant, Carlos A. Bolaños-Guzmán et al.

Ketamine, a dissociative anesthetic and psychedelic compound, has revolutionized the field of psychopharmacology by showing robust, and rapid-acting antidepressant activity in patients suffering from major depressive disorder (MDD), suicidal tendencies, and treatment-resistant depression (TRD). Ketamine’s efficacy, however, is transient, and patients must return to the clinic for repeated...

The Acute Toxic and Neurotoxic Effects of 3,4-methylenedioxymethamphetamine are More Pronounced in Adolescent than Adult Mice

Behavioural Brain Research December 3, 2019 N. Chitre, M. Bagwell, Kevin S. Murnane

3,4-methylenedioxymethamphetamine (MDMA) recently achieved breakthrough status from the Food and Drug Administration (FDA) for post-traumatic stress disorder (PTSD). However, evidence indicates that exposure to toxic doses of 3,4-methylenedioxymethamphetamine (MDMA) can lead to long-lasting dysregulation of brain monoaminergic neurotransmitters, primarily from studies conducted in young adult...

Ketamine reverses the impaired fear memory extinction and accompanied depressive-like behaviors in adolescent mice.

Behavioural Brain Research November 6, 2019 Mei-Dan Wei, Yuhong Wang, Kun Lu et al.

Post-traumatic stress disorder (PTSD) is a chronic and disabling condition arising after exposure to a severe traumatic event, which affects approximately eight percent of the population. The underlying neurobiology of PTSD, however, has only been partially understood. The exploration of fear memory and its extinction has been the subject to increase our understanding of PTSD. Our previous...

Long-lasting effects of repeated ketamine administration in adult and adolescent rats.

Behavioural Brain Research September 2, 2019 M L Shawn Bates, Keith A Trujillo

Initiation of ketamine use often occurs in adolescence, yet little is known about long-term consequences when use begins in this developmental period. The current experiments were designed to examine the effects of repeated exposure to ketamine in adolescence on behavior in adulthood. We examined locomotor activity, as well as cognitive function, in animals that received repeated administration...

Rodent ketamine depression-related research: Finding patterns in a literature of variability

Behavioural Brain Research August 13, 2019 Andrew J. Polis, Paul J. Fitzgerald, Pho J. Hale et al. 58 citations

Discovering that the anesthetic drug ketamine has rapidly acting antidepressant effects in many individuals with major depression is one of the most important findings in clinical psychopharmacology in recent decades. The initial report of these effects in human subjects was based on a foundation of rodent preclinical studies carried out in the 1990s, and subsequent investigation has included...

Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model.

Behavioural Brain Research August 1, 2019 Zhongwei Xiong, Yuko Fujita, Kai Zhang et al.

Inflammatory bone markers may play a role in the antidepressant actions of (R)-ketamine in susceptible mice after chronic social defeat stress (CSDS). In this study, we compared the effects of (R)-ketamine and its final metabolite (2R,6R)-hydroxynorketamine (HNK) in depression-like phenotypes, inflammatory bone markers and bone mineral density (BMD) in CSDS susceptible mice. We measured plasma...

Phencyclidine increased while isolation rearing did not affect progressive ratio responding in rats: Investigating potential models of amotivation in schizophrenia.

Behavioural Brain Research May 17, 2019 Nurith Amitai, Susan B Powell, Jared W Young

Schizophrenia is a debilitating neurodevelopmental disorder affecting 1% of the global population with heterogeneous symptoms including positive, negative, and cognitive. While treatment for positive symptoms exists, none have been developed to treat negative symptoms. Animal models of schizophrenia are required to test targeted treatments and since patients exhibit reduced effort (breakpoints)...